About Careers Internship MedBlog Contact us

CRISPR/Cas9 Tool may Help Suppress Malarial Parasites in Mosquitoes

by Rishika Gupta on March 12, 2018 at 6:00 PM
CRISPR/Cas9 Tool may Help Suppress Malarial Parasites in Mosquitoes

Using CRISPR/Cas9, a gene editing tool gene, the FREP1 gene can be inactivated to reduce mosquitoes vulnerability to Plasmodium parasite, a genus that causes malaria in humans. The findings of this study are published in the Journal of PLOS Pathogens.

Inside an Anopheles gambiae (A. gambiae) mosquito, Plasmodium undergoes a series of infection steps before reaching the mosquito's salivary gland, from which it spreads to bitten humans. This infection cycle relies on the activity of several mosquito proteins. Recently developed CRISPR-Cas9 tools offer new opportunities to study these proteins and determine whether they can be targeted to block malaria transmission.


Dimopoulos group had previously identified and examined several mosquito proteins involved in Plasmodium infection, including fibrinogen-related protein 1 (FREP1). A vaccine candidate based on targeting FREP1 was recently developed, but Dimopoulos' group took a different approach. They used a CRISPR/Cas9 technique to inactivate the FREP1 gene in A. gambiae mosquitos and explore the effects on malaria parasite infection.

The team found that FREP1 inactivation via CRISPR/Cas9 significantly suppressed infection of the mosquitoes with both human and rodent Plasmodium parasites. This supports potential for CRISPR/Cas9 technology in altering the genomes of wild mosquito populations to prevent the spread of malaria, which kills nearly 500,000 people worldwide every year.

However, the permanent inactivation of FREP1 in all mosquito stages and tissues also resulted in fitness costs for the mosquitoes, including reduced blood-feeding ability, lower fertility, a lower egg hatching rate, slowed development, and reduced longevity after feeding on blood. This raises concerns that mosquitoes with permanently inactivated FREP1 would not be able to compete with non-mutant mosquitoes in the wild effectively enough to block malaria transmission. The investigators are now exploring ways to inactivate FREP1 in the gut of adult female mosquitoes only, with the hope to reduce the fitness cost while retaining resistance to the malaria parasite.

Nonetheless, the findings highlight the potential for CRISPR/Cas9 gene editing techniques to inactivate parasite-host factors and improve understanding of malaria. Further research could also explore strategies to enable mosquitoes with inactivated FREP1 to successfully compete with non-mutants.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Dengue News

Bengaluru Records 4,427 Dengue Cases This Year
Bengaluru witnessed 1,649 dengue cases in July, followed by 1,589 in August, and as of September, 416 cases have been reported.
Dengue Virus Grows More Virulent in Warmer Temperatures
In warmer weather with sporadic rainfall boosting mosquito breeding, the risk of a more potent dengue virus emerging and causing severe disease rises.
School Children Enrolled on a Dengue Awareness Spree
Delhi Health Minister Saurabh Bhardwaj held a meeting to review the preparedness to tackle vector-borne diseases like dengue in Delhi.
Consult a Doctor Before Taking Medicines to Treat Dengue, Malaria or Chikungunya
Mosquito-borne diseases like dengue, malaria and chikungunya cases expected to ramp up after the recent rains. Consult a doctor before taking any medicine.
New Smartphone Clip-on can Detect Zika Virus in Blood Samples: Study
The clip-on detector is small and researchers are developing even smaller and similar devices to detect other mosquito-borne viruses.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

CRISPR/Cas9 Tool may Help Suppress Malarial Parasites in Mosquitoes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests